Company Filing History:
Years Active: 2024-2025
Title: Innovations of Sung David C Kim
Introduction
Sung David C Kim is a notable inventor based in Westwood, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for various mental health disorders. With a total of 2 patents to his name, his work is recognized for its potential impact on treatment options.
Latest Patents
Sung David C Kim's latest patents include Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[B]pyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate. These compounds are identified as CaV1.2 activators and are aimed at treating a range of conditions such as schizophrenia, bipolar disorder, major depressive disorder, substance use disorder, ADHD, Phelan-McDermid Syndrome, autism spectrum disorder, multiple sclerosis, frontotemporal dementia, Alzheimer's disease, Brugada Syndrome, Short QT syndrome, and early repolarization syndrome.
Career Highlights
Sung David C Kim is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in the pharmaceutical industry, contributing to advancements in mental health treatments.
Collaborations
Throughout his career, Sung David C Kim has collaborated with notable colleagues, including Zaixing Li and Chui Lu. These collaborations have further enhanced the research and development of his patented compounds.
Conclusion
Sung David C Kim's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving mental health treatment options. His work continues to pave the way for advancements in medical science.